Effect of Patient Age on Outcomes in Breast Reconstruction: Results from a Multicenter Prospective Study
Overview
Gynecology & Obstetrics
Affiliations
Background: Although >40% of new breast cancer diagnoses in the US are in older women, few studies have assessed the outcomes of post-mastectomy reconstruction in this population. Our objective was to evaluate age effects on postoperative complications and patient-reported outcomes in women undergoing breast reconstruction, and to investigate whether age effects differ between reconstructive procedure types.
Study Design: Eligible patients in the Mastectomy Reconstruction Outcomes Consortium study from 11 institutions (57 providers) in North America were analyzed. Two-year complications and patient-reported outcomes via BREAST-Q domains were compared across younger (younger than 45 years), middle-aged (45 to 60 years), and older (older than 60 years) women. Mixed-effects regression models were used, controlling for a range of demographic and clinical covariates.
Results: A total of 1,531 patients were studied: 494 younger, 803 middle-aged, and 234 older. Age was not a significant predictor of complications. For sexual well-being 2 years post-reconstruction, older women reported 4.25 (p = 0.04) higher mean scores with implant procedures, and 10.39 (p < 0.01) higher mean scores with autologous procedures compared with younger women. No age effect was seen with implant procedures with regard to physical and psychosocial well-being; however, older women who underwent autologous procedures reported 6.07 (p < 0.01) higher physical, and 8.21 (p < 0.01) higher psychosocial well-being scores than younger women.
Conclusions: Age did not significantly affect complication rates. Older women demonstrated higher sexual well-being for both procedures, and better satisfaction and physical and psychosocial well-being than younger women with autologous procedures. Post-mastectomy reconstruction is a viable option for older patients, with risks and benefits comparable with those in younger women.
Harvey K, Johnson L, Sinai P, Mills N, White P, Holcombe C Br J Surg. 2025; 112(2).
PMID: 39996483 PMC: 11851068. DOI: 10.1093/bjs/znaf032.
Baglien B, Kumar N, Kennedy S, Bekele M, Hoyte-Williams P, Ezeome E Plast Reconstr Surg Glob Open. 2025; 13(2):e6495.
PMID: 39974770 PMC: 11838158. DOI: 10.1097/GOX.0000000000006495.
Implants versus autologous tissue flaps for breast reconstruction following mastectomy.
Rocco N, Catanuto G, Accardo G, Velotti N, Chiodini P, Cinquini M Cochrane Database Syst Rev. 2024; 10:CD013821.
PMID: 39479986 PMC: 11526434. DOI: 10.1002/14651858.CD013821.pub2.
Xiao J, Zhou L, Luo C, Han Y, Huang Z Front Endocrinol (Lausanne). 2024; 15:1414402.
PMID: 39220362 PMC: 11361993. DOI: 10.3389/fendo.2024.1414402.
De Luca A, Amabile M, Frusone F, Tripodi D, Costanzo M, La Torre G Gland Surg. 2024; 13(7):1164-1177.
PMID: 39175697 PMC: 11336787. DOI: 10.21037/gs-24-58.